Davide Lombardi

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Diana Crivellari, Olivia Pagani, Andrea Veronesi et al. · Annals of Oncology · 2001 · 150 citations · Full text

Neuro-oncology, Advanced Breast Cancer, Breast Oncology +7

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Karin Ribi, Weixiu Luo, Jürg Bernhard et al. · Journal of Clinical Oncology · 2016 · 123 citations · Full text

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Domenica Lorusso, Gabriella Ferrandina, Nicoletta Colombo et al. · Gynecologic Oncology · 2019 · 94 citations

Medicine, Mito End-2, Gynecology +6

Familial breast cancer: characteristics and outcome of BRCA 1–2 positive and negative cases

Andrea Veronesi, Clelia de Giacomi, Maria Donatella Magri et al. · BMC Cancer · 2005 · 86 citations · Full text

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Gianmaria Miolo, Elena Muraro, Donatella Caruso et al. · Oncotarget · 2016 · 85 citations · Full text

Breast Oncology, Metabolomic Profiling, Pathology +18